This has resulted in an increasing number of lawsuits being filed against the manufacturers
That happens sometimes with GLP-1s, since there are versions of the drug, like Ozempic, approved for type 2 diabetes but not obesity management
Leah Liszak, Meghan Etsey, Yun Weisholtz, MD-PhD on behalf of AMWA Gender Equity Task Force Diabetes care has entered an era of precision therapeutics: we no longer treat blood sugar as a single entity but rather tailor regimens to comorbidities, risk profiles, and, critically, individual biology
Sharma AN, Ligade SS, Sharma JN, Shukla P, Elased KM, Lucot JB
Safety considerations and disclaimers A GLP-1 plotter is an educational and planning tool
About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features 2026 Google LLC